These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
23. [Barrett's oesophagus: endoscopic diagnosis and follow-up]. Ponsot P Ann Chir; 2006 Jan; 131(1):3-6. PubMed ID: 16376849 [TBL] [Abstract][Full Text] [Related]
25. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Weston AP; Sharma P Am J Gastroenterol; 2002 Dec; 97(12):2998-3006. PubMed ID: 12492182 [TBL] [Abstract][Full Text] [Related]
26. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Sharma P; Bansal A; Mathur S; Wani S; Cherian R; McGregor D; Higbee A; Hall S; Weston A Gastrointest Endosc; 2006 Aug; 64(2):167-75. PubMed ID: 16860063 [TBL] [Abstract][Full Text] [Related]
27. Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus. Lim CH; Rotimi O; Dexter SP; Axon AT Gastrointest Endosc; 2006 Aug; 64(2):195-9. PubMed ID: 16860068 [TBL] [Abstract][Full Text] [Related]
28. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study. van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412 [TBL] [Abstract][Full Text] [Related]
29. KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate. Bowers SP; Mattar SG; Waring PJ; Galloway K; Nasir A; Pascal R; Hunter JG Surg Endosc; 2003 Jan; 17(1):49-54. PubMed ID: 12364985 [TBL] [Abstract][Full Text] [Related]
30. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Srivastava A; Hornick JL; Li X; Blount PL; Sanchez CA; Cowan DS; Ayub K; Maley CC; Reid BJ; Odze RD Am J Gastroenterol; 2007 Mar; 102(3):483-93; quiz 694. PubMed ID: 17338734 [TBL] [Abstract][Full Text] [Related]
31. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135 [TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study. van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809 [TBL] [Abstract][Full Text] [Related]
33. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia. Wolfsen HC Expert Rev Med Devices; 2005 Nov; 2(6):713-23. PubMed ID: 16293098 [TBL] [Abstract][Full Text] [Related]
34. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666 [TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Foroulis CN; Thorpe JA Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of endoscopic spray cryotherapy for Barrett's dysplasia: results of the National Cryospray Registry. Ghorbani S; Tsai FC; Greenwald BD; Jang S; Dumot JA; McKinley MJ; Shaheen NJ; Habr F; Coyle WJ Dis Esophagus; 2016 Apr; 29(3):241-7. PubMed ID: 25708903 [TBL] [Abstract][Full Text] [Related]
37. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy. Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102 [TBL] [Abstract][Full Text] [Related]
38. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study. Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320 [TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation for total Barrett's eradication: a description of the endoscopic technique, its clinical results and future prospects. Pouw RE; Sharma VK; Bergman JJ; Fleischer DE Endoscopy; 2008 Dec; 40(12):1033-40. PubMed ID: 19065488 [TBL] [Abstract][Full Text] [Related]
40. Esophageal radiofrequency ablation for the treatment of intestinal metaplasia, low grade dysplasia, and high grade dysplasia. Force SD; Miller DL Semin Thorac Cardiovasc Surg; 2008; 20(4):305-9. PubMed ID: 19251169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]